November 10, 2016
Bristol-Myers to develop Nitto's investigational anti-fibrosis drug
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug